POSC122 Cost-Effectiveness of ALPHA-2 Adrenergic Agonist (LOFEXIDINE) and Long-Acting Injectables for Treatment of Opioid Use Disorder
Jan 1, 2022, 00:00
10.1016/j.jval.2021.11.526
https://www.valueinhealthjournal.com/article/S1098-3015(21)02321-4/fulltext
Title :
POSC122 Cost-Effectiveness of ALPHA-2 Adrenergic Agonist (LOFEXIDINE) and Long-Acting Injectables for Treatment of Opioid Use Disorder
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)02321-4&doi=10.1016/j.jval.2021.11.526
First page :
Section Title :
Open access? :
No
Section Order :
10066